The shares of Emerson Electric Company (NYSE:EMR) and Boston Scientific Corporation (NYSE:BSX) were among the active stocks of the last trading sessions. Emerson Electric Company (NYSE:EMR) declined to -0.47% closing at the price of $69.62 whereas the shares of Boston Scientific Corporation (NYSE:BSX) declined -0.49% with the decrease of -0.18 points closing at the price of $36.81. Emerson Electric Company has currently increase 0.46% in its stock over the period of 6-months while its rival Boston Scientific Corporation added 22.95% in the previous 6-months.
Now we have to analyze the facts that if the stocks were worthy off investors’ money? The facts to analyze here are risks, profitability, returns and price trends.
Returns and Profitability
Profitability and returns are the main reason of investment, the investors are looking for profits that they get and return they should expect over the period of time.
The first and foremost return that is considered while making an investment is the ROI or Return on Investment. The ROI is the ratio between the profit against the cost of investment. Currently the ROI of Emerson Electric Company (NYSE:EMR) is 13.7% while the ROI of Boston Scientific Corporation (NYSE:BSX) is 10.4%. Another figure that is to be considered while analyzing the profitability of a share is its EBITDA margin, EMR’s EBITDA Margin is 12.9 whereas BSX’s is 21.83.
Both the profitability ratios suggest a mixed sentiment for Emerson Electric Company (NYSE:EMR) and Boston Scientific Corporation (NYSE:BSX).
EPS & Surprise Factor
Emerson Electric Company (NYSE:EMR) reported $1.12/share EPS for the previous quarter where analysts were predicting an EPS to be $0.86/share Thus beating the analyst Estimates with a Surprise Factor of 30.2 Percent. While, Boston Scientific Corporation (NYSE:BSX) reported EPS of $0.35/share in the last quarter. The analysts projected EPS of $0.34/share depicting a Surprise of 2.9 Percent.
Taking a look at Earnings per Share, Emerson Electric Company tends to be beating the analyst estimates more than Boston Scientific Corporation. so EMR is more profitable than BSX.
Technical Analysis of Emerson Electric Company & Boston Scientific Corporation
Moving average convergence divergence (MACD) shows that Emerson Electric Company (NYSE:EMR) is on a PRICE RELATIVITY trend While Boston Scientific Corporation (NYSE:BSX) is on PRICE RELATIVITY trend. The trend for the past 10-days shows that the Emerson Electric Company was in BULLISH territory and Boston Scientific Corporation was in BULLISH territory.
EMR’s current statistics gauge that the stock candle is BEARISH with HIGH volatility. While BSX’s candle is BEARISH with HIGH.
EPS Growth Rate: EMR’s 17.24% versus BSX’s 10.7%
Another shareholder value can be analyzed through the EPS growth rate; the next 5 years EPS growth rate is predicted by the analysts after the analyzing the previous trends. The next 5 year EPS growth rate of Emerson Electric Company (NYSE:EMR) is predicted at 17.24% while Boston Scientific Corporation (NYSE:BSX) stands at 10.7%. These numbers suggest that EMR is more suitable investment in terms of EPS growth rate.
Financial Risk and Liquidity Concerns
The current ratio and the debt ratio are the two ratios that show the investor how quickly the company is able to payout its debt and how quickly it can cover its obligations. The current ratio of EMR stands at 1.2 while BSX is at 0.8 whereas the debt ratio of the prior is 0.71 while the debt ratio of the later is 0.8.
The values of the both ratios suggest that one is more liquid and other investment is more risk free.
While making an investment, another main factor to consider before investing is the analyst recommendation on the scale of 1 to 5 where 1 is strong buy, 2 is buy, 3 is hold, 4 is Sell and 5 is strong sell. Analyst recommend 2.3 for EMR and 1.5 for BSX which means EMR has Hold rating whereas BSX has Buy rating.
Another recommendation of analyst that is to be considered worthy is the price target. The mare price or price trend does not suggest the suitability of a stock. The price target set by analyst is also to be considered while investing as it suggests to what extent the stock will rise or fall in the near future. The price target set for EMR is $79.95 which is 12.92% of its current price while BSX has price target of 41.88 which is 12.11% of its current price.
Valuation is the process of determining the company’s worth for an investor, the valuation ratios give an insight to that worthiness.
EMR currently has price to earning P/E ratio of 21.74 whereas BSX has 33.74 while the forward P/E ratio for the prior stands at 18.6 and for the later it depicts the value of 23.36.
The price to Book P/B for EMR is 5.21, Price to Sale is at 2.59 and for BSX these ratios stand at 6.15 and 5.29.